1
|
Fahal A, Smith DJ, Nyaoke B, Asiedu K, Falves F, Warusavithanas S, Argaw D, Hay R. Towards enhanced control of mycetoma: a roadmap to achieve the UN's sustainable development goals by 2030. Trans R Soc Trop Med Hyg 2024:trae016. [PMID: 38530874 DOI: 10.1093/trstmh/trae016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Revised: 01/03/2024] [Accepted: 03/07/2024] [Indexed: 03/28/2024] Open
Abstract
Mycetoma is a neglected tropical disease (NTD) with devastating morbidity and stigma. Despite increased awareness and international collaboration, the burden of mycetoma is largely unknown and diagnosis and treatment are difficult. Addressing mycetoma globally aligns with several United Nation's Sustainable Development Goals (SDGs). Little progress has been made since the WHO's NTD roadmap publication in 2020. The Global Mycetoma Working Group proposes an enhanced mycetoma-control roadmap to meet the SDGs, stimulate progress and improve the lives of patients experiencing mycetoma. By aligning mycetoma management with the goals and targets of this enhanced roadmap, it becomes possible to leverage existing resources, infrastructure and partnerships to improve the lives of affected individuals and communities. This updated assessment is designed for the benefit of health workers and providers in mycetoma-endemic areas, NTD government officials, civil society and funding and implementing agencies.
Collapse
Affiliation(s)
- Ahmed Fahal
- The Mycetoma Research Center, University of Khartoum, Khartoum, Sudan
| | - Dallas J Smith
- Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA
| | - Borna Nyaoke
- Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland
| | - Kingsley Asiedu
- Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
| | - Fabiana Falves
- Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland
| | | | - Daniel Argaw
- Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
| | | |
Collapse
|
2
|
Otašević S, Hay R. Editorial: Superficial fungal infections. Front Cell Infect Microbiol 2023; 13:1285771. [PMID: 37790909 PMCID: PMC10543233 DOI: 10.3389/fcimb.2023.1285771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Accepted: 09/04/2023] [Indexed: 10/05/2023] Open
Affiliation(s)
- Suzana Otašević
- Department of Microbiology and immunology, University of Niš, Niš, Serbia
| | - Roderick Hay
- Department of Dermatology, King’s College London, London, United Kingdom
| |
Collapse
|
3
|
Henning MAS, Hay R, Rodriguez-Cerdeira C, Szepietowski JC, Piraccini BM, Ferreirós MP, Arabatzis M, Sergeev A, Nenoff P, Kotrekhova L, Nowicki RJ, Faergemann J, Padovese V, Prohic A, Skerlev M, Schmid-Grendelmeier P, Sigurgeirsson B, Gaitanis G, Lecerf P, Saunte DML. Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis. J Eur Acad Dermatol Venereol 2023. [PMID: 36912427 DOI: 10.1111/jdv.18982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2023] [Accepted: 02/07/2023] [Indexed: 03/14/2023]
Abstract
Malassezia is a lipophilic yeast that is a part of the human mycobiome. Malassezia folliculitis appears when the benign colonization of the hair follicles, by the Malassezia yeasts, becomes symptomatic with pruritic papules and pustules. Although Malassezia folliculitis is common in hospital departments, diagnosing and treating it varies among dermatologists and countries. The European Academy of Dermatology and Venereology Mycology Task Force Malassezia folliculitis working group has, therefore, sought to develop these recommendations for the diagnosis and management of Malassezia folliculitis. Recommendations comprise methods for diagnosing Malassezia folliculitis, required positive findings before starting therapies and specific treatment algorithms for individuals who are immunocompetent, immunocompromised or who have compromised liver function. In conclusion, this study provides a clinical strategy for diagnosing and managing Malassezia folliculitis.
Collapse
Affiliation(s)
- M A S Henning
- Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.,Department of Clinical Medicine, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark
| | - R Hay
- King's College London, London, UK
| | | | - J C Szepietowski
- Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
| | - B M Piraccini
- Dermatology, IRCCS Policlinico di Sant'Orsola, Bologna, Italy.,Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum University of Bologna, Bologna, Italy
| | - M P Ferreirós
- Department of Dermatology, Faculty of Medicine, University of Santiago de Compostela, A Coruña, Spain
| | - M Arabatzis
- Dermatology Department, Medical School, University of Thessaloniki, Thessaloniki, Greece
| | - A Sergeev
- All-Russian National Academy of Mycology, Moscow, Russia
| | - P Nenoff
- Laboratory of Medical Microbiology, Mölbis, Germany
| | - L Kotrekhova
- Department of Dermatovenereology, North Western State Medical University, Saint Petersburg, Russia
| | - R J Nowicki
- Department of Dermatology, Venereology, and Allergology, Medical University of Gdansk, Gdańsk, Poland
| | - J Faergemann
- Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - V Padovese
- Department of Dermatology and Venereology, Genitourinary Clinic, Mater Dei Hospital, Msida, Malta.,International Foundation for Dermatology, Migrants Health Dermatology Working Group, London, UK
| | - A Prohic
- Department of Dermatovenereology, University Sarajevo School of Science and Technology, Sarajevo Medical School, Sarajevo, Bosnia and Herzegovina
| | - M Skerlev
- Department of Dermatology and Venereology, Zagreb University School of Medicine and Zagreb University Hospital, Zagreb, Croatia
| | - P Schmid-Grendelmeier
- Allergy Unit, Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, Zurich, Switzerland
| | - B Sigurgeirsson
- Department of Dermatology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - G Gaitanis
- Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
| | - P Lecerf
- Department of Dermatology, University Hospital Brugmann & Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium
| | - D M L Saunte
- Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.,Department of Clinical Medicine, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
4
|
Hay R. William Fairbank Doe. BMJ 2022. [DOI: 10.1136/bmj.o2566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
5
|
Miller KM, Lamagni T, Hay R, Cannon JW, Marks M, Bowen AC, Kaslow DC, Cherian T, Seale AC, Pickering J, Daw JN, Moore HC, Van Beneden C, Carapetis JR, Manning L. Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis. Open Forum Infect Dis 2022; 9:S25-S30. [PMID: 36128406 PMCID: PMC9474943 DOI: 10.1093/ofid/ofac267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Accepted: 05/25/2022] [Indexed: 11/13/2022] Open
Abstract
Abstract
Cellulitis is an acute bacterial infection of the dermis and subcutaneous tissue usually found complicating a wound, ulcer, or dermatosis. This article provides guidelines for the surveillance of cellulitis. The primary objectives of cellulitis surveillance are to (1) monitor trends in rates of infection, (2) describe the demographic and clinical characteristics of patients with cellulitis, (3) estimate the frequency of complications, and (4) describe the risk factors associated with primary and recurrent cellulitis. This article includes case definitions for clinical cellulitis and group A streptococcal cellulitis, based on clinical and laboratory evidence, and case classifications for an initial and recurrent case. It is expected that surveillance for cellulitis will be for all-cause cellulitis, rather than specifically for Strep A cellulitis. Considerations of the type of surveillance are also presented, including identification of data sources and surveillance type. Minimal surveillance necessary for cellulitis is facility-based, passive surveillance. Prospective, active, facility-based surveillance is recommended for estimates of pathogen-specific cellulitis burden. Participant eligibility, surveillance population, and additional surveillance considerations such as active follow-up of cases, the use of International Classification of Disease diagnosis codes, and microbiological sampling of cases are discussed. Finally, the core data elements to be collected on case report forms are presented.
Collapse
Affiliation(s)
- Kate M Miller
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
| | | | - Roderick Hay
- St John’s Institute of Dermatology, King’s College London , London , United Kingdom
| | - Jeffrey W Cannon
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
- Department of Global Health and Population, Harvard T.H. Chan School of Public Health , Boston, Massachusetts , USA
| | - Michael Marks
- Clinical Research Department, Faculty of Infectious Diseases, London School of Hygiene & Tropical Medicine , London , United Kingdom
- Hospital for Tropical Diseases and Division of Infection and Immunity, University College London Hospitals , London , United Kingdom
- Division of Infection and Immunity, University College London , London , United Kingdom
| | - Asha C Bowen
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
- Department of Infectious Diseases, Perth Children’s Hospital , Nedlands, Western Australia , Australia
- Faculty of Health and Medicine, University of Western Australia , Nedlands, Western Australia , Australia
| | | | | | - Anna C Seale
- UK Health Security Agency , London , United Kingdom
- London School of Hygiene & Tropical Medicine , London , United Kingdom
- University of Warwick , Coventry , United Kingdom
| | - Janessa Pickering
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
| | - Jessica N Daw
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
| | - Hannah C Moore
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
| | | | - Jonathan R Carapetis
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
- Faculty of Health and Medicine, University of Western Australia , Nedlands, Western Australia , Australia
| | - Laurens Manning
- Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia
- Infectious Diseases Department, Fiona Stanley Hospital , Perth, Western Australia , Australia
- School of Medicine and Pharmacology, Harry Perkins Research Institute, Fiona Stanley Hospital, University of Western Australia , Perth, Western Australia , Australia
| |
Collapse
|
6
|
Miller KM, Carapetis JR, Cherian T, Hay R, Marks M, Pickering J, Cannon JW, Lamagni T, Romani L, Moore HC, Van Beneden CA, Barth DD, Bowen AC, Carapetis J, Van Beneden C, Kaslow D, Cherian T, Lamagni T, Engel M, Cannon J, Moore H, Bowen A, Seale A, Kang G, Watkins D, Kariuki S. Standardization of Epidemiological Surveillance of Group A Streptococcal Impetigo. Open Forum Infect Dis 2022; 9:S15-S24. [PMID: 36128409 PMCID: PMC9474945 DOI: 10.1093/ofid/ofac249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Impetigo is a highly contagious bacterial infection of the superficial layer of skin. Impetigo is caused by group A Streptococcus (Strep A) and Staphylococcus aureus, alone or in combination, with the former predominating in many tropical climates. Strep A impetigo occurs mainly in early childhood, and the burden varies worldwide. It is an acute, self-limited disease, but many children experience frequent recurrences that make it a chronic illness in some endemic settings. We present a standardized surveillance protocol including case definitions for impetigo including both active (purulent, crusted) and resolving (flat, dry) phases and discuss the current tests used to detect Strep A among persons with impetigo. Case classifications that can be applied are detailed, including differentiating between incident (new) and prevalent (existing) cases of Strep A impetigo. The type of surveillance methodology depends on the burden of impetigo in the community. Active surveillance and laboratory confirmation is the preferred method for case detection, particularly in endemic settings. Participant eligibility, surveillance population and additional considerations for surveillance of impetigo, including examination of lesions, use of photographs to document lesions, and staff training requirements (including cultural awareness), are addressed. Finally, the core elements of case report forms for impetigo are presented and guidance for recording the course and severity of impetigo provided.
Collapse
Affiliation(s)
- Kate M Miller
- Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Perth, Western Australia , Australia
| | - Jonathan R Carapetis
- Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Perth, Western Australia , Australia
- Perth Children’s Hospital , Perth, Western Australia , Australia
| | | | - Roderick Hay
- St John’s Institute of Dermatology, King’s College London , United Kingdom
| | - Michael Marks
- Clinical Research Department, Faculty of Infectious Diseases, London School of Hygiene and Tropical Medicine , London , United Kingdom
- Hospital for Tropical Diseases, University College , London , United Kingdom
- Division of Infection and Immunity, University College London , London , United Kingdom
| | - Janessa Pickering
- Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Perth, Western Australia , Australia
| | - Jeffrey W Cannon
- Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Perth, Western Australia , Australia
- Department of Global Health and Population, Harvard T. H. Chan School of Public Health , Boston, Massachusetts , USA
| | - Theresa Lamagni
- United Kingdom Health Security Agency , London , United Kingdom
| | - Lucia Romani
- The Kirby Institute, University of New South Wales Sydney , Sydney , Australia
- Murdoch Children’s Research Group , Melbourne , Australia
| | - Hannah C Moore
- Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Perth, Western Australia , Australia
| | - Chris A Van Beneden
- CDC Foundation, Centers for Disease Control and Prevention , Atlanta, Georgia , USA
| | - Dylan D Barth
- Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Perth, Western Australia , Australia
| | - Asha C Bowen
- Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Perth, Western Australia , Australia
- Perth Children’s Hospital , Perth, Western Australia , Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Hay R, Gupta A. Continuous spinal anaesthesia. BJA Educ 2022; 22:295-297. [PMID: 36097572 PMCID: PMC9463624 DOI: 10.1016/j.bjae.2022.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Revised: 03/16/2022] [Accepted: 03/27/2022] [Indexed: 10/18/2022] Open
|
8
|
Porter E, Kanaan A, Carty K, Stapleton PJ, Hay R, Field S. Tinea capitis with multiple isolates: The interaction of nature, animal and child. Pediatr Dermatol 2022; 39:324-325. [PMID: 35106808 DOI: 10.1111/pde.14931] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Revised: 01/10/2022] [Accepted: 01/16/2022] [Indexed: 11/29/2022]
Abstract
Tinea capitis is an infection of the scalp and hair commonly seen in the pediatric population. Detection of multiple dermatophytes is unusual, and true mixed infections have been rarely reported. Herein, we describe an 8-year-old girl with tinea capitis revealing three different dermatophyte isolates that highlight the clinical challenge posed by this phenomenon.
Collapse
Affiliation(s)
- Emma Porter
- University Hospital Limerick, Limerick, Ireland
| | | | | | | | | | | |
Collapse
|
9
|
Mavura D, Chapa P, Sabushimike D, Kini L, Hay R. Mycetoma in Moshi, Tanzania. Trans R Soc Trop Med Hyg 2021; 115:340-342. [PMID: 33438021 DOI: 10.1093/trstmh/traa190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 12/16/2020] [Accepted: 12/21/2020] [Indexed: 11/12/2022] Open
Abstract
The geographic spread of the neglected tropical disease mycetoma is still poorly understood, largely because there is no mechanism for official reporting and the general lack of identification facilities in many regions. Nonetheless many countries in the tropics have such cases. This brief report is submitted to provide an example of recent experience of mycetoma in six patients presenting to a single centre in Tanzania.
Collapse
Affiliation(s)
- Daudi Mavura
- Regional Dermatology Training Centre, Kilimanjaro Christian Medical Center, Moshi, Tanzania
| | - Peter Chapa
- Regional Dermatology Training Centre, Kilimanjaro Christian Medical Center, Moshi, Tanzania
| | - Doriane Sabushimike
- Regional Dermatology Training Centre, Kilimanjaro Christian Medical Center, Moshi, Tanzania
| | - Lulyritha Kini
- Regional Dermatology Training Centre, Kilimanjaro Christian Medical Center, Moshi, Tanzania
| | - Roderick Hay
- St Johns Institute of Dermatology, King's College London, London, UK
| |
Collapse
|
10
|
Asiedu K, Marks M, Hay R. Podoconiosis, skin-NTDs and global health. Trans R Soc Trop Med Hyg 2021; 114:887-888. [PMID: 33169171 DOI: 10.1093/trstmh/traa069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 07/23/2020] [Indexed: 11/13/2022] Open
Affiliation(s)
- Kingsley Asiedu
- Department of Control of Neglected Tropical Diseases, World Health Organisation, Geneva, Switzerland
| | - Michael Marks
- Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
| | - Roderick Hay
- Kings College London and the International Foundation for Dermatology, London, United Kingdom
| |
Collapse
|
11
|
Roberto E, Guadalupe CL, Guadalupe EC, Hay R. Mycetoma and the Community Dermatology Program, Mexico. Trans R Soc Trop Med Hyg 2021; 115:383-386. [PMID: 33479763 DOI: 10.1093/trstmh/traa199] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Revised: 12/16/2020] [Accepted: 12/22/2020] [Indexed: 11/14/2022] Open
Abstract
The Community Dermatology Program established in the state of Guerrero, Mexico for almost 30 y provides an adaptable method of detecting and monitoring skin neglected tropical diseases such as mycetoma, which is endemic in the state. The program utilises general and thematic teaching elements combined with distance learning through teledermatology, direct patient consultations and close collaboration with community teams. Using this approach, a picture of mycetoma in Guerrero has emerged, with a focal hot spot located in the southern part of the state in the Costa Chica region. Although in much of Mexico Nocardia infections dominate, in this area there are also substantial numbers of cases of eumycetoma. This combined approach provides a means of early case detection and long-term surveillance through targeted use of a small specialist team.
Collapse
Affiliation(s)
- Estrada Roberto
- Dermatología Comunitaria México-Centro Dermatológico "Ramón Ruiz Maldonado", Acapulco, Guerrero, Mexico
| | - Chávez-López Guadalupe
- Dermatología Comunitaria México-Centro Dermatológico "Ramón Ruiz Maldonado", Acapulco, Guerrero, Mexico
| | | | - Roderick Hay
- International Foundation for Dermatology, London, UK
| |
Collapse
|
12
|
Rundle C, Fortugno A, Maghfour J, Presley C, Pulsipher K, Husayn S, Naldi L, Chosidow O, Hay R, Dellavalle R. Evaluating the World Health Organization Model List of Essential Medicines for skin disease. Br J Dermatol 2021; 185:451-453. [DOI: 10.1111/bjd.20081] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 03/03/2021] [Accepted: 03/16/2021] [Indexed: 11/30/2022]
Affiliation(s)
- C.W. Rundle
- Department of Dermatology University of Colorado School of Medicine Aurora CO USA
| | - A.P. Fortugno
- Medical School University of Tennessee Health Science Center Memphis TN USA
| | - J. Maghfour
- Department of Medicine Tulane University School of Medicine New Orleans LA USA
| | - C.L. Presley
- College of Osteopathic Medicine Rocky Vista University Parker CO USA
| | - K. Pulsipher
- College of Osteopathic Medicine Rocky Vista University Parker CO USA
| | - S.S. Husayn
- College of Osteopathic Medicine Rocky Vista University Parker CO USA
| | - L. Naldi
- Department of Dermatology Azienda Sanitaria Berica, Ospedale San Bortolo Vicenza Italy
- Study Center Italian Group for Epidemiological Research in Dermatology (GISED) Bergamo Italy
| | - O. Chosidow
- Department of Dermatology AP‐HP Hôpital Henri Mondor UPEC Créteil France
| | - R. Hay
- St Johns Institute of Dermatology Kings College London London SE1 UK
| | - R.P. Dellavalle
- Department of Dermatology University of Colorado School of Medicine Aurora CO USA
- Dermatology Service U.S. Department of Veterans Affairs Eastern Colorado Health Care System Aurora Colorado USA
- Department of Epidemiology Colorado School of Public Health University of Colorado Anschutz Medical Campus Aurora Colorado USA
| |
Collapse
|
13
|
Hampton PJ, Berth-Jones J, Duarte Williamson CE, Hay R, Leslie TA, Porter I, Rauz S, Seukeran D, Winn RT, Hashme M, Exton LS, Mohd Mustapa MF, Manounah L. British Association of Dermatologists guidelines for the management of people with rosacea 2021. Br J Dermatol 2021; 185:725-735. [PMID: 33993465 DOI: 10.1111/bjd.20485] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/13/2021] [Indexed: 11/29/2022]
Affiliation(s)
- P J Hampton
- Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK
| | - J Berth-Jones
- Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK.,Patient representative
| | | | - R Hay
- St John's Institute of Dermatology, Kings College London, London, SE1 9RT, UK
| | - T A Leslie
- Royal Free Hospital, London, NW3 2QG, UK
| | | | - S Rauz
- University of Birmingham, Birmingham, B15 2TT, UK.,Birmingham & Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, B18 7QH, UK.,Royal College of Ophthalmologists, NW1 2HD, UK
| | - D Seukeran
- South Tees Hospitals NHS Foundation Trust, Middlesbrough, TS4 3BW, UK
| | - R T Winn
- Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK
| | - M Hashme
- British Association of Dermatologists, Willan House, 4 Fitzroy Square, London, W1T 5HQ, UK
| | - L S Exton
- British Association of Dermatologists, Willan House, 4 Fitzroy Square, London, W1T 5HQ, UK
| | - M F Mohd Mustapa
- British Association of Dermatologists, Willan House, 4 Fitzroy Square, London, W1T 5HQ, UK
| | - L Manounah
- British Association of Dermatologists, Willan House, 4 Fitzroy Square, London, W1T 5HQ, UK
| | | |
Collapse
|
14
|
Abstract
Scabies is a neglected tropical disease (NTD) of the skin that is caused by the mite Sarcoptes scabiei. It is considered to be an important public health problem in many regions. The disease is at its most prevalent in low-resource countries where there are overcrowded living conditions coupled with poor hygiene. In some regions, mass drug administration using ivermectin is a key population-based approach to the control of scabies. Before starting a patient on specific treatment, confirming the diagnosis by accurate and rapid identification of the organism is critical. Different laboratory-based techniques for scabies have been developed in the last few decades. These include direct microscopy and histopathology. More recently, serological testing, dermoscopy and different molecular techniques have been developed as diagnostic methods for scabies. To date, none of these, apart from microscopy and dermoscopy, has been translated into routine clinical laboratory practice. A simple point-of-care or laboratory test would provide a rapid and confirmed diagnosis and early institution of effective treatment. In this review we present an update on the laboratory techniques currently in use for the identification of scabies.
Collapse
Affiliation(s)
- Emmanuel Edwar Siddig
- Nile University, Faculty of Medicine, Khartoum, Sudan.,Erasmus Medical Center, University Medical Center Rotterdam, Department of Medical Microbiology and Infectious Diseases, Wytemaweg 80 3015 CN, Rotterdam, The Netherlands
| | - Roderick Hay
- Kings College London, Guys Campus, London SE1 9RT,UK
| |
Collapse
|
15
|
McMahon DE, Oyesiku L, Amerson E, Beltraminelli H, Chang AY, Forrestel A, Hay R, Knapp A, Kovarik C, Maurer T, Norton SA, Rehmus W, Van Hees C, Wanat KA, Williams VL, Fuller LC, Freeman EE. Identifying gaps in global health dermatology: a survey of GLODERM members. Br J Dermatol 2021; 185:212-214. [PMID: 33657642 DOI: 10.1111/bjd.19889] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2020] [Revised: 02/03/2021] [Indexed: 12/16/2022]
|
16
|
Affiliation(s)
- C Flohr
- Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London and Guy's and St Thomas' NHS Foundation Trust, London, UK
| | - R Hay
- King's College London, London, UK
| |
Collapse
|
17
|
Rodríguez‐Cerdeira C, Martínez‐Herrera E, Szepietowski J, Pinto‐Almazán R, Frías‐De‐León M, Espinosa‐Hernández V, Chávez‐Gutiérrez E, García‐Salazar E, Vega‐Sánchez D, Arenas R, Hay R, Saunte D. A systematic review of worldwide data on tinea capitis: analysis of the last 20 years. J Eur Acad Dermatol Venereol 2020; 35:844-883. [DOI: 10.1111/jdv.16951] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2020] [Accepted: 09/03/2020] [Indexed: 12/18/2022]
Affiliation(s)
- C. Rodríguez‐Cerdeira
- Efficiency, Quality, and Costs in Health Services Research Group (EFISALUD) Health Research InstituteSERGAS‐UVIGO Vigo Spain
- Dermatology Department Hospital do Meixoeiro and University of Vigo Vigo Spain
- Psichodermatology Task for (CILAD) Buenos Aires Argentina
| | - E. Martínez‐Herrera
- Efficiency, Quality, and Costs in Health Services Research Group (EFISALUD) Health Research InstituteSERGAS‐UVIGO Vigo Spain
- Psichodermatology Task for (CILAD) Buenos Aires Argentina
- Unidad de Investigación Hospital Regional de Alta Especialidad de Ixtapaluca Ixtapaluca México
| | - J.C. Szepietowski
- Department of Dermatology, Venereology and Allergology Wroclaw Medical University Wroclaw Poland
| | - R. Pinto‐Almazán
- Unidad de Investigación Hospital Regional de Alta Especialidad de Ixtapaluca Ixtapaluca México
| | - M.G. Frías‐De‐León
- Unidad de Investigación Hospital Regional de Alta Especialidad de Ixtapaluca Ixtapaluca México
| | - V.M. Espinosa‐Hernández
- Unidad de Investigación Hospital Regional de Alta Especialidad de Ixtapaluca Ixtapaluca México
| | - E. Chávez‐Gutiérrez
- Unidad de Investigación Hospital Regional de Alta Especialidad de Ixtapaluca Ixtapaluca México
| | - E. García‐Salazar
- Psichodermatology Task for (CILAD) Buenos Aires Argentina
- Unidad de Investigación Hospital Regional de Alta Especialidad de Ixtapaluca Ixtapaluca México
| | - D.C. Vega‐Sánchez
- Psichodermatology Task for (CILAD) Buenos Aires Argentina
- Sección de Micología Hospital General ‘Dr. Manuel Gea González’ Ciudad de México México
| | - R. Arenas
- Efficiency, Quality, and Costs in Health Services Research Group (EFISALUD) Health Research InstituteSERGAS‐UVIGO Vigo Spain
- Psichodermatology Task for (CILAD) Buenos Aires Argentina
- Sección de Micología Hospital General ‘Dr. Manuel Gea González’ Ciudad de México México
| | - R. Hay
- St Johns Institute of Dermatology King's College London London UK
| | - D.M. Saunte
- Department of Dermatology Zealand University Hospital Roskilde Denmark
- Health Sciences Faculty University of Copenhagen Copenhagen Denmark
| |
Collapse
|
18
|
Hay R. New BJD Associate Editor. Br J Dermatol 2020; 183:794. [DOI: 10.1111/bjd.19559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
Bernardes Filho F, Neto AT, Duarte RD, Ramos Paiolo FV, Towersey L, Hay R. Woman with Life-Threatening Widespread Rash. J Emerg Med 2020; 59:e139-e141. [PMID: 32712035 DOI: 10.1016/j.jemermed.2020.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2019] [Revised: 05/14/2020] [Accepted: 06/01/2020] [Indexed: 06/11/2023]
Affiliation(s)
- Fred Bernardes Filho
- Dermatology Division, Department of Medical Clinics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Department of Internal Medicine, Hospital São Francisco, Ribeirão Preto, São Paulo, Brazil
| | - Aloysio Taliberti Neto
- Department of Internal Medicine, Hospital São Francisco, Ribeirão Preto, São Paulo, Brazil
| | - Rafael Diniz Duarte
- Department of Internal Medicine, Hospital São Francisco, Ribeirão Preto, São Paulo, Brazil
| | | | - Loan Towersey
- AIDS Division, Carlos Tortelly Municipal Hospital, Ministry of Health, Niterói, Rio de Janeiro, Brazil
| | - Roderick Hay
- International Foundation for Dermatology, London, United Kingdom
| |
Collapse
|
20
|
Hay R. New BJD Associate Editor. Br J Dermatol 2020; 183:600. [DOI: 10.1111/bjd.19497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
21
|
de Sousa MDG, Santana VD, Passoni LFC, Bernardes Filho F, Towersey L, Hay R. Tuberculous Dactylitis in an HIV-Infected Patient. J Emerg Med 2020; 59:712-713. [PMID: 32684381 DOI: 10.1016/j.jemermed.2020.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Revised: 05/14/2020] [Accepted: 06/01/2020] [Indexed: 11/15/2022]
Affiliation(s)
- Marcos Davi Gomes de Sousa
- Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil; National Institute of Infectious Diseases (NIID), Oswaldo Cruz Foundation (Fiocruz), Brazilian Ministry of Health, Rio de Janeiro, Brazil
| | - Vinicius Delucas Santana
- Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil
| | | | - Fred Bernardes Filho
- Dermatology Division, Department of Medical Clinics, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
| | - Loan Towersey
- AIDS Division, Carlos Tortelly Municipal Hospital, Ministry of Health, Niterói, Rio de Janeiro, Brazil
| | - Roderick Hay
- International Foundation for Dermatology, London, United Kingdom
| |
Collapse
|
22
|
Rundle C, Fortugno A, Chosidow O, Naldi L, Hay R, Dellavalle R. 519 Evaluating world health organization essential medicines list for dermatologic disease. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
23
|
Hay R. Trophic leprosy ulcers – what is a secondary infection? LEPROSY REV 2020. [DOI: 10.47276/lr.91.2.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Yotsu RR, Comoé CC, Ainyakou GT, Konan N, Akpa A, Yao A, Aké J, Vagamon B, Abbet Abbet R, Bedimo R, Hay R. Impact of common skin diseases on children in rural Côte d'Ivoire with leprosy and Buruli ulcer co-endemicity: A mixed methods study. PLoS Negl Trop Dis 2020; 14:e0008291. [PMID: 32421709 PMCID: PMC7274456 DOI: 10.1371/journal.pntd.0008291] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2020] [Revised: 06/05/2020] [Accepted: 04/14/2020] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Skin-related neglected tropical diseases (skin NTDs) occur against a background of a very high prevalence of common skin diseases in sub-Saharan Africa. In this study, we examined the knowledge, attitude and practices (KAP) and the impact of common skin diseases in children living in a leprosy and Buruli ulcer (BU) co-endemic district in a west African country of Côte d'Ivoire, in order to help inform disease control efforts for skin NTDs. METHODS AND PRINCIPLE FINDINGS Fourteen focus group discussions (FGDs) with schoolchildren, 5 FGDs with parents of a child affected with skin disease(s), and 27 in-depth semi-structured interviews with key personnel were conducted. The Children's Dermatology Quality of Life Index (CDLQI) questionnaire was applied to 184 schoolchildren with skin diseases. We found that there was ignorance or neglect towards skin diseases in general, due to their high prevalence and also the perceived minimal impact on children's daily lives. While the median score for the CDLQI questionnaire was 5 (IQR 2-9) out of 30, a range of scores was observed. Symptoms such as pruritus and experiencing bullying by classmates contributed to reduction in their quality of life. Poor hygiene was considered as a major cause of skin diseases. CONCLUSIONS/SIGNIFICANCE Despite their high impact on affected populations, we observed a high level of ignorance and neglect toward common skin diseases. There is a critical need to increase awareness of skin diseases, or skin health promotion, which supports changing of the health-seeking behaviour for skin conditions. This will aid in early detection and treatment of the skin NTDs, in addition to providing benefits for those affected by other skin diseases. Educational opportunities should be utilized to their utmost. One would be associated with water, sanitation, and hygiene (WASH) strategies, but careful messages need to be developed and delivered.
Collapse
Affiliation(s)
- Rie Roselyne Yotsu
- School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
- Department of Dermatology, National Center for Global Health and Medicine, Tokyo, Japan
- Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, New Orleans, United States of America
- * E-mail:
| | - Colombe Coffie Comoé
- Department of Social Sciences, University of Felix Houphouët Boigny (UFHB), Abidjan, Côte d’Ivoire
- Laboratoire d’Étude et de Recherches Interdisciplinaire en Sciences Sociales (LERISS), Abidjan, Côte d’Ivoire
| | - Germaine Taïba Ainyakou
- Laboratoire d’Étude et de Recherches Interdisciplinaire en Sciences Sociales (LERISS), Abidjan, Côte d’Ivoire
- Department of Social Sciences, University of Peleforo Gon Coulibaly, Korhogo, Côte d’Ivoire
| | | | - Amari Akpa
- MAP International Côte d’Ivoire, Abidjan, Côte d’Ivoire
| | - Aubin Yao
- MAP International Côte d’Ivoire, Abidjan, Côte d’Ivoire
| | - Julien Aké
- MAP International Côte d’Ivoire, Abidjan, Côte d’Ivoire
| | - Bamba Vagamon
- Raoul Follereau Institute Côte d’Ivoire, Adzopé, Côte d’Ivoire
- Department of Dermatology, Université Alassane Ouattara, Bouaké, Côte d’Ivoire
| | | | - Roger Bedimo
- Division of Infectious Diseases, University of Texas Southwestern, Dallas, United States of America
| | - Roderick Hay
- International Foundation for Dermatology, London, United Kingdom
| |
Collapse
|
25
|
Hay R, Denning DW, Bonifaz A, Queiroz-Telles F, Beer K, Bustamante B, Chakrabarti A, Chavez-Lopez MDG, Chiller T, Cornet M, Estrada R, Estrada-Chavez G, Fahal A, Gomez BL, Li R, Mahabeer Y, Mosam A, Soavina Ramarozatovo L, Rakoto Andrianarivelo M, Rapelanoro Rabenja F, van de Sande W, Zijlstra EE. The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus Report. Trop Med Infect Dis 2019; 4:E122. [PMID: 31554262 PMCID: PMC6958312 DOI: 10.3390/tropicalmed4040122] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 08/18/2019] [Accepted: 09/06/2019] [Indexed: 02/07/2023] Open
Abstract
The diagnosis of fungal Neglected Tropical Diseases (NTD) is primarily based on initial visual recognition of a suspected case followed by confirmatory laboratory testing, which is often limited to specialized facilities. Although molecular and serodiagnostic tools have advanced, a substantial gap remains between the desirable and the practical in endemic settings. To explore this issue further, we conducted a survey of subject matter experts on the optimal diagnostic methods sufficient to initiate treatment in well-equipped versus basic healthcare settings, as well as optimal sampling methods, for three fungal NTDs: mycetoma, chromoblastomycosis, and sporotrichosis. A survey of 23 centres found consensus on the key role of semi-invasive sampling methods such as biopsy diagnosis as compared with swabs or impression smears, and on the importance of histopathology, direct microscopy, and culture for mycetoma and chromoblastomycosis confirmation in well-equipped laboratories. In basic healthcare settings, direct microscopy combined with clinical signs were reported to be the most useful diagnostic indicators to prompt referral for treatment. The survey identified that the diagnosis of sporotrichosis is the most problematic with poor sensitivity across the most widely available laboratory tests except fungal culture, highlighting the need to improve mycological diagnostic capacity and to develop innovative diagnostic solutions. Fungal microscopy and culture are now recognized as WHO essential diagnostic tests and better training in their application will help improve the situation. For mycetoma and sporotrichosis, in particular, advances in identifying specific marker antigens or genomic sequences may pave the way for new laboratory-based or point-of-care tests, although this is a formidable task given the large number of different organisms that can cause fungal NTDs.
Collapse
Affiliation(s)
- Roderick Hay
- The International Foundation for Dermatology, London W1T 5HQ, UK.
| | - David W Denning
- The Global Fund for Fungal Infections, 1208 Geneva, Switzerland, and the University of Manchester, Manchester M13 9PL, UK.
| | - Alexandro Bonifaz
- Hospital General de México, "Dr. Eduardo Liceaga", CP 06720, Mexico.
| | - Flavio Queiroz-Telles
- Department of Public Health, Hospital de Clinicas, Federal University of Parana, 80060-900 Curriba, Parana, Brazil.
| | - Karlyn Beer
- Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
| | - Beatriz Bustamante
- Tropical Medicine, Infectious Diseases and Dermatology Department at the Hospital Cayetano Heredia, Lima 15102, Peru.
| | | | | | - Tom Chiller
- Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
| | - Muriel Cornet
- Laboratoire de Parasitologie-Mycologie, Grenoble Alpes University, CNRS, Grenoble INP, CHU Grenoble Alpes, F-38000, France.
| | - Roberto Estrada
- Community Dermatology Mexico C.A., Acapulco 39850, Guerrero, Mexico.
| | | | - Ahmed Fahal
- The Mycetoma Research Centre, Khartoum, Soba University Hospital, P.O. Box 102, Sudan.
| | - Beatriz L Gomez
- School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111211, Colombia.
| | - Ruoyu Li
- Peking University First Hospital, Research Centre for Medical Mycology, Peking University, Beijing 100034, China.
| | - Yesholata Mahabeer
- Department of Medical Microbiology, National Health Laboratory Services and School of Laboratory Medicine and Medical Sciences, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Berea, Durban 4001, South Africa.
| | - Anisa Mosam
- Nelson R Mandela School of Medicine, University of Kwazulu Natal, Berea, Durban 4001, South Africa.
| | | | | | | | - Wendy van de Sande
- Erasmus MC, Department of Medical Microbiology and Infectious Diseases, 3000 CA Rotterdam, The Netherlands.
| | | |
Collapse
|
26
|
Bernardes Filho F, Bernardes A, Towersey L, Hay R. A Man with an Unusual Foreign Body. J Emerg Med 2019; 57:e59-e60. [PMID: 31229305 DOI: 10.1016/j.jemermed.2019.04.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Accepted: 04/22/2019] [Indexed: 06/09/2023]
Affiliation(s)
- Fred Bernardes Filho
- Dermatology Division, Department of Medical Clinics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Emergency Department, Hospital Imaculada Conceição da Sociedade Portuguesa de Beneficência, Ribeirão Preto, São Paulo, Brazil
| | - Andreia Bernardes
- Emergency Department, Hospital Imaculada Conceição da Sociedade Portuguesa de Beneficência, Ribeirão Preto, São Paulo, Brazil
| | - Loan Towersey
- AIDS Division, Carlos Tortelly Municipal Hospital, Ministry of Health, Niterói, Rio de Janeiro, Brazil
| | - Roderick Hay
- International Foundation for Dermatology, London, United Kingdom
| |
Collapse
|
27
|
Otašević S, Momčilović S, Golubović M, Ignjatović A, Rančić N, Đorđević M, Ranđelović M, Hay R, Arsić‐Arsenijević V. Species distribution and epidemiological characteristics of superficial fungal infections in Southeastern Serbia. Mycoses 2019; 62:458-465. [DOI: 10.1111/myc.12900] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2018] [Revised: 12/16/2018] [Accepted: 01/22/2019] [Indexed: 11/30/2022]
Affiliation(s)
- Suzana Otašević
- Department of Microbiology and ImmunologyFaculty of MedicineUniversity of Niš Niš Serbia
- Center of Microbiology and ParasitologyPublic Health Institute Niš Niš Serbia
| | - Stefan Momčilović
- Department of Microbiology and ImmunologyFaculty of MedicineUniversity of Niš Niš Serbia
| | - Milan Golubović
- Department of Microbiology and ImmunologyFaculty of MedicineUniversity of Niš Niš Serbia
| | | | - Nataša Rančić
- Center for Disease Control and PreventionPublic Health Institute Niš Niš Serbia
| | | | - Marina Ranđelović
- Department of Microbiology and ImmunologyFaculty of MedicineUniversity of Niš Niš Serbia
- Center of Microbiology and ParasitologyPublic Health Institute Niš Niš Serbia
| | | | | |
Collapse
|
28
|
Barraza LL, Tolomelli JB, Cunha CG, Bernardes Filho F, Towersey L, Hay R, Schechtman RC, da Costa Nery JA. Facial Cutaneous Sporotrichosis in a Boy. J Emerg Med 2019; 56:222-223. [DOI: 10.1016/j.jemermed.2018.10.031] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2018] [Accepted: 10/25/2018] [Indexed: 10/27/2022]
|
29
|
Bernardes Filho F, Alves ADO, Towersey L, Hay R, Montag A, Coutinho ALF, Lupi O, Barreto JG, Frade MAC. The skin health of fishermen in Guanabara Bay, Rio de Janeiro, Brazil. Int J Dermatol 2019; 58:483-490. [DOI: 10.1111/ijd.14382] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2018] [Revised: 11/13/2018] [Accepted: 12/31/2018] [Indexed: 11/28/2022]
Affiliation(s)
- Fred Bernardes Filho
- Dermatology Division; Department of Medical Clinics; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto São Paulo Brazil
| | | | - Loan Towersey
- AIDS Division; Carlos Tortelly Municipal Hospital; Ministry of Health; Niteroi Rio de Janeiro Brazil
| | - Roderick Hay
- International Foundation for Dermatology; London UK
| | | | - Ana L. F. Coutinho
- Instituto de Dermatologia Professor Rubem David Azulay; Santa Casa da Misericórdia do Rio de Janeiro; Rio de Janeiro Brazil
| | - Omar Lupi
- Dermatology Department, Gaffree and Guinle University Hospital; Federal University of the State of Rio de Janeiro; Rio de Janeiro Brazil
| | - Josafá G. Barreto
- Dermato-Immunology Laboratory; Federal University of Pará; Marituba Pará Brazil
- Spatial Epidemiology Laboratory; Federal University of Pará; Castanhal Pará Brazil
| | - Marco A. C. Frade
- Dermatology Division; Department of Medical Clinics; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto São Paulo Brazil
| |
Collapse
|
30
|
Steel N, Ford JA, Newton JN, Davis ACJ, Vos T, Naghavi M, Glenn S, Hughes A, Dalton AM, Stockton D, Humphreys C, Dallat M, Schmidt J, Flowers J, Fox S, Abubakar I, Aldridge RW, Baker A, Brayne C, Brugha T, Capewell S, Car J, Cooper C, Ezzati M, Fitzpatrick J, Greaves F, Hay R, Hay S, Kee F, Larson HJ, Lyons RA, Majeed A, McKee M, Rawaf S, Rutter H, Saxena S, Sheikh A, Smeeth L, Viner RM, Vollset SE, Williams HC, Wolfe C, Woolf A, Murray CJL. Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2018; 392:1647-1661. [PMID: 30497795 PMCID: PMC6215773 DOI: 10.1016/s0140-6736(18)32207-4] [Citation(s) in RCA: 153] [Impact Index Per Article: 25.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 08/17/2018] [Accepted: 08/30/2018] [Indexed: 12/15/2022]
Abstract
BACKGROUND Previous studies have reported national and regional Global Burden of Disease (GBD) estimates for the UK. Because of substantial variation in health within the UK, action to improve it requires comparable estimates of disease burden and risks at country and local levels. The slowdown in the rate of improvement in life expectancy requires further investigation. We use GBD 2016 data on mortality, causes of death, and disability to analyse the burden of disease in the countries of the UK and within local authorities in England by deprivation quintile. METHODS We extracted data from the GBD 2016 to estimate years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and attributable risks from 1990 to 2016 for England, Scotland, Wales, Northern Ireland, the UK, and 150 English Upper-Tier Local Authorities. We estimated the burden of disease by cause of death, condition, year, and sex. We analysed the association between burden of disease and socioeconomic deprivation using the Index of Multiple Deprivation. We present results for all 264 GBD causes of death combined and the leading 20 specific causes, and all 84 GBD risks or risk clusters combined and 17 specific risks or risk clusters. FINDINGS The leading causes of age-adjusted YLLs in all UK countries in 2016 were ischaemic heart disease, lung cancers, cerebrovascular disease, and chronic obstructive pulmonary disease. Age-standardised rates of YLLs for all causes varied by two times between local areas in England according to levels of socioeconomic deprivation (from 14 274 per 100 000 population [95% uncertainty interval 12 791-15 875] in Blackpool to 6888 [6145-7739] in Wokingham). Some Upper-Tier Local Authorities, particularly those in London, did better than expected for their level of deprivation. Allowing for differences in age structure, more deprived Upper-Tier Local Authorities had higher attributable YLLs for most major risk factors in the GBD. The population attributable fractions for all-cause YLLs for individual major risk factors varied across Upper-Tier Local Authorities. Life expectancy and YLLs have improved more slowly since 2010 in all UK countries compared with 1990-2010. In nine of 150 Upper-Tier Local Authorities, YLLs increased after 2010. For attributable YLLs, the rate of improvement slowed most substantially for cardiovascular disease and breast, colorectal, and lung cancers, and showed little change for Alzheimer's disease and other dementias. Morbidity makes an increasing contribution to overall burden in the UK compared with mortality. The age-standardised UK DALY rate for low back and neck pain (1795 [1258-2356]) was higher than for ischaemic heart disease (1200 [1155-1246]) or lung cancer (660 [642-679]). The leading causes of ill health (measured through YLDs) in the UK in 2016 were low back and neck pain, skin and subcutaneous diseases, migraine, depressive disorders, and sense organ disease. Age-standardised YLD rates varied much less than equivalent YLL rates across the UK, which reflects the relative scarcity of local data on causes of ill health. INTERPRETATION These estimates at local, regional, and national level will allow policy makers to match resources and priorities to levels of burden and risk factors. Improvement in YLLs and life expectancy slowed notably after 2010, particularly in cardiovascular disease and cancer, and targeted actions are needed if the rate of improvement is to recover. A targeted policy response is also required to address the increasing proportion of burden due to morbidity, such as musculoskeletal problems and depression. Improving the quality and completeness of available data on these causes is an essential component of this response. FUNDING Bill & Melinda Gates Foundation and Public Health England.
Collapse
Affiliation(s)
| | | | | | - Adrian C J Davis
- AD CAVE Solutions Ltd, London, UK; Imperial College London, London, UK
| | - Theo Vos
- Institute for Health Metrics and Evaluation, Seattle, WA, USA
| | - Mohsen Naghavi
- Institute for Health Metrics and Evaluation, Seattle, WA, USA
| | - Scott Glenn
- Institute for Health Metrics and Evaluation, Seattle, WA, USA
| | | | | | | | | | | | | | | | | | | | | | | | - Carol Brayne
- Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK
| | - Traolach Brugha
- Department of Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK
| | - Simon Capewell
- Department of Public Health & Policy, Institute of Psychology, Health & Society, University of Liverpool, Liverpool, UK
| | - Josip Car
- Imperial College London, London, UK; Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
| | - Cyrus Cooper
- MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
| | | | | | - Felix Greaves
- Public Health England, London, UK; Imperial College London, London, UK
| | | | - Simon Hay
- Institute for Health Metrics and Evaluation, Seattle, WA, USA
| | - Frank Kee
- UKCRC Centre of Excellence for Public Health Research (NI), Queens University of Belfast, Belfast, UK
| | - Heidi J Larson
- Institute for Health Metrics and Evaluation, Seattle, WA, USA; London School of Hygiene & Tropical Medicine, London, UK
| | - Ronan A Lyons
- Health Data Research UK, Swansea University, Swansea, UK
| | | | - Martin McKee
- London School of Hygiene & Tropical Medicine, London, UK
| | | | | | | | - Aziz Sheikh
- Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
| | - Liam Smeeth
- London School of Hygiene & Tropical Medicine, London, UK
| | | | | | - Hywel C Williams
- Centre of Evidence-Based Dermatology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | | | - Anthony Woolf
- Bone and Joint Research Group, Royal Cornwall Hospital, Truro, UK
| | | |
Collapse
|
31
|
Abstract
Treatment of superficial fungal infections has come a long way. This has, in part, been through the development and evaluation of new drugs. However, utilising new strategies, such as identifying variation between different species in responsiveness, e.g., in tinea capitis, as well as seeking better ways of ensuring adequate concentrations of drug in the skin or nail, and combining different treatment methods, have played equally important roles in ensuring steady improvements in the results of treatment. Yet there are still areas where we look for improvement, such as better remission and cure rates in fungal nail disease, and the development of effective community treatment programmes to address endemic scalp ringworm.
Collapse
|
32
|
Bernardes Filho F, Queiroz RM, Towersey L, Hay R, Valentin MVN. Chronic Multifocal Paracoccidioidomycosis: Pulmonary and Cutaneous Involvement. J Emerg Med 2018; 55:e57-e60. [PMID: 29793811 DOI: 10.1016/j.jemermed.2018.04.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2018] [Accepted: 04/11/2018] [Indexed: 06/08/2023]
Affiliation(s)
- Fred Bernardes Filho
- Dermatology Division, Department of Medical Clinics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - Rodolfo Mendes Queiroz
- Centro Avançado de Diagnóstico por Imagem, Hospital São Francisco, Ribeirão Preto, São Paulo, Brazil
| | - Loan Towersey
- AIDS Division, Carlos Tortelly Municipal Hospital, Ministry of Health, Niterói, Rio de Janeiro, Brazil
| | - Roderick Hay
- International Foundation for Dermatology, London, United Kingdom
| | | |
Collapse
|
33
|
Yotsu RR, Kouadio K, Vagamon B, N’guessan K, Akpa AJ, Yao A, Aké J, Abbet Abbet R, Tchamba Agbor Agbor B, Bedimo R, Ishii N, Fuller LC, Hay R, Mitjà O, Drechsler H, Asiedu K. Skin disease prevalence study in schoolchildren in rural Côte d'Ivoire: Implications for integration of neglected skin diseases (skin NTDs). PLoS Negl Trop Dis 2018; 12:e0006489. [PMID: 29771976 PMCID: PMC5976208 DOI: 10.1371/journal.pntd.0006489] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Revised: 05/30/2018] [Accepted: 05/02/2018] [Indexed: 12/18/2022] Open
Abstract
Background Early detection of several skin-related neglected tropical diseases (skin NTDs)–including leprosy, Buruli ulcer, yaws, and scabies- may be achieved through school surveys, but such an approach has seldom been tested systematically on a large scale in endemic countries. Additionally, a better understanding of the spectrum of skin diseases and the at-risk populations to be encountered during such surveys is necessary to facilitate the process. Methods We performed a school skin survey for selected NTDs and the spectrum of skin diseases, among primary schoolchildren aged 5 to 15 in Côte d’Ivoire, West Africa. This 2-phase survey took place in 49 schools from 16 villages in the Adzopé health district from November 2015 to January 2016. The first phase involved a rapid visual examination of the skin by local community healthcare workers (village nurses) to identify any skin abnormality. In a second phase, a specialized medical team including dermatologists performed a total skin examination of all screened students with any skin lesion and provided treatment where necessary. Results Of a total of 13,019 children, 3,504 screened positive for skin lesions and were listed for the next stage examination. The medical team examined 1,138 of these children. The overall prevalence of skin diseases was 25.6% (95% CI: 24.3–26.9%). The predominant diagnoses were fungal infections (n = 858, prevalence: 22.3%), followed by inflammatory skin diseases (n = 265, prevalence: 6.9%). Skin diseases were more common in boys and in children living along the main road with heavy traffic. One case of multi-bacillary type leprosy was detected early, along with 36 cases of scabies. Our survey was met with very good community acceptance. Conclusion We carried out the first large-scale integrated, two-phase pediatric multi-skin NTD survey in rural Côte d’Ivoire, effectively reaching a large population. We found a high prevalence of skin diseases in children, but only limited number of skin NTDs. With the lessons learned, we plan to expand the project to a wider area to further explore its potential to better integrate skin NTD screening in the public health agenda. Integration of neglected tropical diseases (NTDs) into the public health agenda has been a priority in global health for the last decade. A common feature shared by several NTDs is skin involvement. Conditions within this group of NTDs have now been classified as skin NTDs to promote wider NTD integration. Several skin NTDs including leprosy, Buruli ulcer, yaws, and scabies are co-endemic in Côte d’Ivoire, West Africa. As children are vulnerable to these diseases, we carried out the first large-scale integrated, multi-skin NTD school survey in a rural district of this country. Our strategy of involving community healthcare workers and dermatologists effectively reached a large population. However, the detection of skin NTDs may have been limited because of the low schooling and attendance rate. We found a high prevalence of skin diseases among schoolchildren (26%), possibly due to poor socio-economic status and air pollution, which requires more attention. This high prevalence of skin diseases posed a challenge for our project as the need for medications and those with dermatological skills exceeded our capacity to reach our initial target population. Our study provides important lessons that will aid the framing of future school skin surveys in sub-Saharan Africa.
Collapse
Affiliation(s)
- Rie Roselyne Yotsu
- Department of Dermatology, National Center for Global Health and Medicine, Tokyo, Japan
- Department of Dermatology, National Suruga Sanatorium, Shizuoka, Japan
- * E-mail: ,
| | - Kouamé Kouadio
- Eco Epidemiology Unit, Pasteur Institute Côte d’Ivoire, Abidjan, Côte d’Ivoire
| | - Bamba Vagamon
- Raoul Follereau Institute Côte d’Ivoire, Adzopé, Côte d’Ivoire
| | | | | | - Aubin Yao
- MAP International West Africa, Abidjan, Côte d’Ivoire
| | - Julien Aké
- MAP International West Africa, Abidjan, Côte d’Ivoire
| | - Rigobert Abbet Abbet
- National Program for Leprosy Control (PNEL), Ministry of Health and Public Hygiene, Abidjan, Côte d’Ivoire
| | | | - Roger Bedimo
- Department of Medicine, VA North Texas Healthcare System, Dallas, Texas, United States of America
- Division of Infectious Diseases, University of Texas Dallas Southwestern, Dallas, Texas, United States of America
| | - Norihisa Ishii
- Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
| | - L. Claire Fuller
- International Foundation for Dermatology
- Dermatology Department, Chelsea and Westminster Hospital, London, United Kingdom
| | | | - Oriol Mitjà
- Skin NTD Program, Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain
| | - Henning Drechsler
- Department of Medicine, VA North Texas Healthcare System, Dallas, Texas, United States of America
- Division of Infectious Diseases, University of Texas Dallas Southwestern, Dallas, Texas, United States of America
| | - Kingsley Asiedu
- Global Buruli Ulcer Initiative, World Health Organization, Geneva, Switzerland
| |
Collapse
|
34
|
Hay R. Donald WR Mackenzie (1929–2017). Rev Iberoam Micol 2018. [DOI: 10.1016/j.riam.2018.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
35
|
Affiliation(s)
- Roderick Hay
- Kings College London, Dermatology Department, Denmark Hill, London SE5 9RS, UK
| |
Collapse
|
36
|
Rouzaud C, Chosidow O, Brocard A, Fraitag S, Scemla A, Anglicheau D, Bouaziz JD, Dupin N, Bougnoux ME, Hay R, Lortholary O, Lanternier F. Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review. Transpl Infect Dis 2018; 20. [PMID: 29094463 DOI: 10.1111/tid.12799] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2017] [Accepted: 07/09/2017] [Indexed: 11/29/2022]
Abstract
OBJECTIVE Severe dermatophytosis is described in immunocompromised patients with defective cellular immunity. We report here a large series and a literature review of severe dermatophytosis in solid-organ transplant (SOT) recipients. METHOD The data main source was a national French retrospective study of severe dermatophytosis in SOT recipients between 2010 and 2016. Inclusion criteria were the presence of dermatophytes in skin culture and 1 severity criteria: dermal invasion by dermatophytes (invasive dermatophytosis) or involvement of at least two body sites or >10% of body surface area (extensive dermatophytosis). RESULTS A total of 12 patients were included (8 men, median age of 56 years [range: 33-71]). Of the 12 patients, 10 underwent kidney transplantation. The median time from transplantation to severe dermatophytosis diagnosis was 16 months [range: 2-94]. Clinical signs of superficial dermatophytosis were present in 8/12 patients before the emergence of severe dermatophytosis. Nine patients had invasive forms and three extensive ones, and nodules of the lower extremities were found in eight. Trichophyton rubrum was isolated in 11 cases. First-line treatment was terbinafine (7/12), posaconazole (3/12), or topical treatment alone (2/12). Immunosuppressive therapy was reduced in 3 patients because of associated infections. Complete response was obtained for 3/3 and 5/9 patients with extensive or invasive forms, respectively, after a median treatment's duration of 2.5 [range: 1.5-5] months and 7.5 months [range: 4-12]. Unrelated deaths (n = 2) and graft function impairment (n = 3) occurred. CONCLUSION Severe dermatophytosis is a late complication in SOT recipients presenting with lower limb nodules, which might be prevented by prompt treatment of superficial dermatophytosis.
Collapse
Affiliation(s)
- Claire Rouzaud
- Infectious Diseases and Tropical Medicine Department, Necker-Pasteur Infectious Diseases Center, Necker-Enfants malades Hospital, AP-HP, IHU Imagine, Paris Descartes University, Paris, France
| | - Olivier Chosidow
- Department of Dermatology, Henri Mondor Hospital, AP-HP, Paris-Est Créteil University, Créteil, France
| | - Anabelle Brocard
- Department of Dermatology, Nantes University Hospital, Nantes, France
| | - Sylvie Fraitag
- Department of Pathology, Necker-Enfants malades Hospital, AP-HP, Paris Descartes University, Paris, France
| | - Anne Scemla
- Department of Nephrology-Transplantation, Necker-Enfants malades Hospital, AP-HP, Paris Descartes Sorbonne Paris Cité University, RTRS Centaure, Labex Transplantex, Paris, France
| | - Dany Anglicheau
- Paris Descartes University, Department of Nephrology-Transplantation, Necker-Enfants malades Hospital, AP-HP, Paris, France
| | | | - Nicolas Dupin
- Department of Dermatology, Cochin Tarnier Hospital, AP-HP, Paris Descartes University, Paris, France
| | - Marie-Elisabeth Bougnoux
- Department of Mycology, Necker-Enfants malades Hospital, AP-HP, Paris Descartes University, Paris, France
| | - Roderick Hay
- Dermatology Department, King's College Hospital NHS Trust, London, UK
| | - Olivier Lortholary
- Infectious Diseases and Tropical Medicine Department, Necker-Pasteur Infectious Diseases Center, Necker-Enfants malades Hospital, AP-HP, IHU Imagine, Paris Descartes University, Paris, France.,National Reference Center for Invasive Mycoses and Antifungals Molecular Mycology Unit, CNRS URA3012, Institut Pasteur, Paris, France
| | - Fanny Lanternier
- Infectious Diseases and Tropical Medicine Department, Necker-Pasteur Infectious Diseases Center, Necker-Enfants malades Hospital, AP-HP, IHU Imagine, Paris Descartes University, Paris, France.,National Reference Center for Invasive Mycoses and Antifungals Molecular Mycology Unit, CNRS URA3012, Institut Pasteur, Paris, France
| | | |
Collapse
|
37
|
Affiliation(s)
- R. Hay
- Kings College London; London U.K
| |
Collapse
|
38
|
Karimkhani C, Colombara DV, Drucker AM, Norton SA, Hay R, Engelman D, Steer A, Whitfeld M, Naghavi M, Dellavalle RP. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis 2017; 17:1247-1254. [PMID: 28941561 PMCID: PMC5700804 DOI: 10.1016/s1473-3099(17)30483-8] [Citation(s) in RCA: 131] [Impact Index Per Article: 18.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/01/2017] [Revised: 07/20/2017] [Accepted: 07/24/2017] [Indexed: 01/01/2023]
Abstract
BACKGROUND Numerous population-based studies have documented high prevalence of scabies in overcrowded settings, particularly among children and in tropical regions. We provide an estimate of the global burden of scabies using data from the Global Burden of Disease (GBD) Study 2015. METHODS We identified scabies epidemiological data sources from an extensive literature search and hospital insurance data and analysed data sources with a Bayesian meta-regression modelling tool, DisMod-MR 2·1, to yield prevalence estimates. We combined prevalence estimates with a disability weight, measuring disfigurement, itch, and pain caused by scabies, to produce years lived with disability (YLDs). With an assumed zero mortality from scabies, YLDs were equivalent to disability-adjusted life-years (DALYs). We estimated DALYs for 195 countries divided into 21 world regions, in both sexes and 20 age groups, between 1990 and 2015. FINDINGS Scabies was responsible for 0·21% of DALYs from all conditions studied by GBD 2015 worldwide. The world regions of east Asia (age-standardised DALYs 136·32), southeast Asia (134·57), Oceania (120·34), tropical Latin America (99·94), and south Asia (69·41) had the greatest burden of DALYs from scabies. Mean percent change of DALY rate from 1990 to 2015 was less than 8% in all world regions, except North America, which had a 23·9% increase. The five individual countries with greatest scabies burden were Indonesia (age-standardised DALYs 153·86), China (138·25), Timor-Leste (136·67), Vanuatu (131·59), and Fiji (130·91). The largest standard deviations of age-standardised DALYs between the 20 age groups were observed in southeast Asia (60·1), Oceania (58·3), and east Asia (56·5), with the greatest DALY burdens in children, adolescents, and the elderly. INTERPRETATION The burden of scabies is greater in tropical regions, especially in children, adolescents, and elderly people. As a worldwide epidemiological assessment, GBD 2015 provides broad and frequently updated measures of scabies burden in terms of skin effects. These global data might help guide research protocols and prioritisation efforts and focus scabies treatment and control measures. FUNDING Bill & Melinda Gates Foundation.
Collapse
Affiliation(s)
- Chante Karimkhani
- Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
| | - Danny V Colombara
- Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
| | - Aaron M Drucker
- Department of Dermatology, Brown University, Providence, RI, USA
| | - Scott A Norton
- Department of Dermatology, Children's National Medical Center, NW Washington DC, USA
| | - Roderick Hay
- Department of Dermatology, King's College Hospital, Denmark Hill, London, UK
| | - Daniel Engelman
- Centre for International Child Health and Murdoch Children's Research Institute, University of Melbourne, Royal Children's Hospital, Melbourne, VIC, Australia
| | - Andrew Steer
- Centre for International Child Health and Murdoch Children's Research Institute, University of Melbourne, Royal Children's Hospital, Melbourne, VIC, Australia
| | - Margot Whitfeld
- Department of Dermatology, St Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia
| | - Mohsen Naghavi
- Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
| | - Robert P Dellavalle
- Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA; Dermatology Service, US Department of Veterans Affairs, Eastern Colorado Health System, Denver, CO, USA
| |
Collapse
|
39
|
Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, Fitzpatrick C, Fuller LC, Garcia Izquierdo B, Hay R, Ishii N, Johnson C, Lazarus JV, Meka A, Murdoch M, Ohene SA, Small P, Steer A, Tabah EN, Tiendrebeogo A, Waller L, Yotsu R, Walker SL, Asiedu K. Integrated Control and Management of Neglected Tropical Skin Diseases. PLoS Negl Trop Dis 2017; 11:e0005136. [PMID: 28103250 PMCID: PMC5245794 DOI: 10.1371/journal.pntd.0005136] [Citation(s) in RCA: 89] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Affiliation(s)
- Oriol Mitjà
- Skin NTDs Program, Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain
- Division of Public Health, School of Medicine and Health Sciences, University of Papua New Guinea, Port Moresby, Papua New Guinea
| | - Michael Marks
- Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
- Hospital for Tropical Diseases, University College London Hospitals NHS Trust, London, United Kingdom
| | - Laia Bertran
- Skin NTDs Program, Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain
| | - Karsor Kollie
- Neglected Tropical and Non Communicable Diseases Program, Ministry of Health, Government of Liberia, Liberia
| | - Daniel Argaw
- Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
| | - Ahmed H. Fahal
- The Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan
| | - Christopher Fitzpatrick
- Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
| | - L. Claire Fuller
- International Foundation for Dermatology, London, United Kingdom
| | | | - Roderick Hay
- International Foundation for Dermatology, London, United Kingdom
| | - Norihisa Ishii
- Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
| | | | - Jeffrey V. Lazarus
- Skin NTDs Program, Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain
| | - Anthony Meka
- Medical Department, German Leprosy and TB Relief Association, Enugu, Nigeria
| | - Michele Murdoch
- Department of Dermatology, Watford General Hospital, Watford, United Kingdom
| | | | - Pam Small
- Department of Microbiology, University of Tennessee, Knoxville, Tennessee, United States of America
| | - Andrew Steer
- Group A Streptococcal Research Group, Murdoch Children’s Research Institute, Melbourne, Victoria, Australia
| | - Earnest N. Tabah
- National Yaws, Leishmaniasis, Leprosy and Buruli ulcer Control Programme, Ministry of Public Health, Yaoundé, Cameroon
| | | | - Lance Waller
- Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America
| | - Rie Yotsu
- Department of Dermatology, National Center for Global Health and Medicine, Tokyo, Japan
| | - Stephen L. Walker
- Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
| | - Kingsley Asiedu
- Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
| |
Collapse
|
40
|
Affiliation(s)
- Z. Laftah
- Skin Infection Clinic Department of Dermatology King's College Hospital NHS Trust, Denmark Hill London SE5 9RS U.K
| | - R. Hay
- Skin Infection Clinic Department of Dermatology King's College Hospital NHS Trust, Denmark Hill London SE5 9RS U.K
| |
Collapse
|
41
|
Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, Hamadeh RR, Moore A, Werdecker A, Gessner BD, Te Ao B, McMahon B, Karimkhani C, Yu C, Cooke GS, Schwebel DC, Carpenter DO, Pereira DM, Nash D, Kazi DS, De Leo D, Plass D, Ukwaja KN, Thurston GD, Yun Jin K, Simard EP, Mills E, Park EK, Catalá-López F, deVeber G, Gotay C, Khan G, Hosgood HD, Santos IS, Leasher JL, Singh J, Leigh J, Jonas JB, Jonas J, Sanabria J, Beardsley J, Jacobsen KH, Takahashi K, Franklin RC, Ronfani L, Montico M, Naldi L, Tonelli M, Geleijnse J, Petzold M, Shrime MG, Younis M, Yonemoto N, Breitborde N, Yip P, Pourmalek F, Lotufo PA, Esteghamati A, Hankey GJ, Ali R, Lunevicius R, Malekzadeh R, Dellavalle R, Weintraub R, Lucas R, Hay R, Rojas-Rueda D, Westerman R, Sepanlou SG, Nolte S, Patten S, Weichenthal S, Abera SF, Fereshtehnejad SM, Shiue I, Driscoll T, Vasankari T, Alsharif U, Rahimi-Movaghar V, Vlassov VV, Marcenes WS, Mekonnen W, Melaku YA, Yano Y, Artaman A, Campos I, MacLachlan J, Mueller U, Kim D, Trillini M, Eshrati B, Williams HC, Shibuya K, Dandona R, Murthy K, Cowie B, Amare AT, Antonio CA, Castañeda-Orjuela C, van Gool CH, Violante F, Oh IH, Deribe K, Soreide K, Knibbs L, Kereselidze M, Green M, Cardenas R, Roy N, Tillmann T, Tillman T, Li Y, Krueger H, Monasta L, Dey S, Sheikhbahaei S, Hafezi-Nejad N, Kumar GA, Sreeramareddy CT, Dandona L, Wang H, Vollset SE, Mokdad A, Salomon JA, Lozano R, Vos T, Forouzanfar M, Lopez A, Murray C, Naghavi M. The Global Burden of Cancer 2013. JAMA Oncol 2016; 1:505-27. [PMID: 26181261 DOI: 10.1001/jamaoncol.2015.0735] [Citation(s) in RCA: 1962] [Impact Index Per Article: 245.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
IMPORTANCE Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies. OBJECTIVE To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013. EVIDENCE REVIEW The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs. FINDINGS In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries. CONCLUSIONS AND RELEVANCE Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments. The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation.
Collapse
Affiliation(s)
| | - Christina Fitzmaurice
- Division of Hematology, Department of Medicine, University of Washington, Seattle2Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Daniel Dicker
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Amanda Pain
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Hannah Hamavid
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Maziar Moradi-Lakeh
- Institute for Health Metrics and Evaluation, University of Washington, Seattle3Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Michael F MacIntyre
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Christine Allen
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Gillian Hansen
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Rachel Woodbrook
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | | | | | | | - Andrea Werdecker
- Institute of Medical Sociology and Social Medicine, Marburg, Germany
| | | | - Braden Te Ao
- Department of Biostatistics and Epidemiology, School of Public Health and Psychosocial Studies, Auckland University of Technology, Auckland, New Zealand
| | - Brian McMahon
- Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
| | - Chante Karimkhani
- College of Physicians and Surgeons, Columbia University, New York, New York
| | - Chuanhua Yu
- Department of Epidemiology and Biostatistics, School of Public Health, Wuhan University, Wuhan, China
| | | | - David C Schwebel
- Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama
| | - David O Carpenter
- Institute for Health and the Environment, University at Albany, Rensselaer, New York
| | - David M Pereira
- Laboratório de Farmacognosia, Departamento de Ciências Químicas, Faculdade de Farmácia, University do Porto, REQUIMTE/LAQV, Porto, Portugal
| | - Denis Nash
- School of Public Health, Hunter College Campus, City University of New York, New York
| | | | | | - Dietrich Plass
- Federal Environment Agency Section on Exposure Assessment and Environmental Health Indicators, Berlin, Germany
| | - Kingsley N Ukwaja
- Department of Internal Medicine, Federal Teaching Hospital, Abakaliki, Nigeria
| | - George D Thurston
- Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York
| | - Kim Yun Jin
- Faculty of Chinese Medicine, Southern University College, Johor, Malaysia
| | - Edgar P Simard
- Rollins School of Public Health, Emory University, Atlanta, Georgia
| | | | - Eun-Kee Park
- Department of Medical Humanities and Social Medicine, Kosin University College of Medicine, Busan, South Korea
| | - Ferrán Catalá-López
- Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Medicines and Healthcare Products Agency (AEMPS), Ministry of Health, Madrid, Spain
| | | | - Carolyn Gotay
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
| | - Gulfaraz Khan
- Department of Microbiology & Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates
| | | | - Itamar S Santos
- Centre for Clinical and Epidemiological Research, University of São Paulo, São Paulo, Brazil
| | | | - Jasvinder Singh
- Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama
| | | | - Jost B Jonas
- Department of Ophthalmology, University of Heidelberg, Mannheim, Germany
| | | | - Juan Sanabria
- Department of Surgery, Case Western Reserve University, Cleveland, Ohio38Nutrition and Preventive Medicine, Chicago Medical School at Cancer Treatment Centers of America, Rosalind Franklin University, Chicago, Illinois
| | - Justin Beardsley
- Nuffield Department of Medicine, Oxford University, Ho Chi Minh City, Vietnam
| | - Kathryn H Jacobsen
- Department of Global and Community Health, George Mason University, Fairfax, Virginia
| | - Ken Takahashi
- Department of Environmental Epidemiology, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Richard C Franklin
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia
| | - Luca Ronfani
- Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy
| | - Marcella Montico
- Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy
| | - Luigi Naldi
- Azienda Ospedaliera papa Giovanni XXIII, Bergamo, Italy
| | | | - Johanna Geleijnse
- Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands
| | - Max Petzold
- Centre for Applied Biostatistics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden48School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
| | | | | | | | | | - Paul Yip
- The University of Hong Kong, Hong Kong, China
| | - Farshad Pourmalek
- Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Paulo A Lotufo
- Centre for Clinical and Epidemiological Research, University of São Paulo, São Paulo, Brazil
| | - Alireza Esteghamati
- Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Graeme J Hankey
- School of Medicine and Pharmacology, University of Western Australia, School of Medicine and Pharmacology, Perth, Australia
| | - Raghib Ali
- Nuffield Department of Population Health, University of Oxford, Oxford, England
| | - Raimundas Lunevicius
- Department of Neuropsychopharmacology, Aintree University Hospital NHS Foundation Trust, Liverpool, England
| | - Reza Malekzadeh
- Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Robert Dellavalle
- Veterans Affairs Eastern Colorado Health Care System, Denver61Department of Dermatology, University of Colorado School of Medicine, Denver
| | - Robert Weintraub
- University of Melbourne, Melbourne, Australia63Royal Children's Hospital, Melbourne, Australia
| | - Robyn Lucas
- National Centre for Epidemiology and Population Health, Research School of Population Health, The Australian National University, Canberra, Australia
| | - Roderick Hay
- International Foundation for Dermatology, London, England
| | - David Rojas-Rueda
- Centre of Research in Environmental Epidemiology (CREAL), Barcelona, Spain
| | | | - Sadaf G Sepanlou
- Digestive Diseases Research Institute, Shariati Hospital, Tehran, Iran
| | - Sandra Nolte
- Charité University Medicine Berlin, Berlin, Germany
| | - Scott Patten
- Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
| | | | | | | | - Ivy Shiue
- Northumbria University, Newcastle upon Tyne, England75University of Edinburgh, Edinburgh, Scotland
| | - Tim Driscoll
- Sydney School of Public Health, University of Sydney, Sydney, Australia
| | - Tommi Vasankari
- UKK Institute for Health Promotion Research, Tampere, Finland
| | | | - Vafa Rahimi-Movaghar
- Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Vasiliy V Vlassov
- National Research University Higher School of Economics, Moscow, Russia
| | - W S Marcenes
- Barts and The London School of Medicine and Dentistry, University of London, London, England
| | | | - Yohannes Adama Melaku
- College of Health Sciences, School of Public Health, Mekelle University, Mekelle, Ethiopia
| | - Yuichiro Yano
- Department of Preventive Medicine, Northwestern University, Chicago, Illinois
| | | | | | - Jennifer MacLachlan
- Victorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, WHO Collaborating Centre for Viral Hepatitis, Melbourne, Australia
| | | | - Daniel Kim
- Department of Health Sciences, Northeastern University, Boston, Massachusetts
| | - Matias Trillini
- Mario Negri Institute for pharmacological Research, Ranica, Italy
| | - Babak Eshrati
- Arak University of Medical Sciences and Health Affairs, Arak, Iran
| | | | | | - Rakhi Dandona
- Public Health Foundation of India, National Capital Region, India
| | - Kinnari Murthy
- Public Health Foundation of India, National Capital Region, India
| | - Benjamin Cowie
- Victorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, WHO Collaborating Centre for Viral Hepatitis, Melbourne, Australia
| | - Azmeraw T Amare
- Department of Epidemiology, University of Groningen, Groningen, the Netherlands
| | | | | | - Coen H van Gool
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Francesco Violante
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - In-Hwan Oh
- Kyung Hee University, Seoul, South Korea
| | - Kedede Deribe
- School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia100Brighton and Sussex Medical School, Brighton, England
| | - Kjetil Soreide
- Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway102University of Bergen, Stavanger, Norway
| | - Luke Knibbs
- Department of Clinical Medicine, The University of Queensland, Brisbane, Australia
| | - Maia Kereselidze
- National Centre for Diseases Control and Public Health, Tbilisi, Georgia
| | - Mark Green
- University of Sheffield, Sheffield, England
| | | | - Nobhojit Roy
- Department of Public Health Sciences, Karolinska Institutet, Mumbai, India
| | | | | | - Yongmei Li
- Genentech Inc, San Francisco, California
| | - Hans Krueger
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
| | - Lorenzo Monasta
- Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy
| | - Subhojit Dey
- Indian Institute of Public Health, National Capital Region, India
| | - Sara Sheikhbahaei
- Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Nima Hafezi-Nejad
- Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - G Anil Kumar
- Public Health Foundation of India, National Capital Region, India
| | | | - Lalit Dandona
- Institute for Health Metrics and Evaluation, University of Washington, Seattle93Public Health Foundation of India, National Capital Region, India
| | - Haidong Wang
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Stein Emil Vollset
- Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway113Norwegian Institute of Public Health, Bergen, Norway
| | - Ali Mokdad
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | | | - Rafael Lozano
- Institute for Health Metrics and Evaluation, University of Washington, Seattle115National Institute of Public Health, Cuernavaca, Mexico
| | - Theo Vos
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | | | - Alan Lopez
- School of Population and Global Health, University of Melbourne, Melbourne, Australia
| | - Christopher Murray
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| | - Mohsen Naghavi
- Institute for Health Metrics and Evaluation, University of Washington, Seattle
| |
Collapse
|
42
|
Nast A, Griffiths C, Hay R, Sterry W, Bolognia J. The 2016 International League of Dermatological Societies' revised glossary for the description of cutaneous lesions. Br J Dermatol 2016; 174:1351-8. [DOI: 10.1111/bjd.14419] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/24/2015] [Indexed: 11/30/2022]
Affiliation(s)
- A. Nast
- Division of Evidence Based Medicine (dEBM) Department of Dermatology Charité – Universitätsmedizin Berlin Charitéplatz 1 D‐10117 Berlin Germany
| | - C.E.M. Griffiths
- Dermatology Centre Salford Royal Hospital University of Manchester Manchester Academic Health Science Centre Manchester U.K
| | - R. Hay
- Department of Dermatology Kings College Hospital London U.K
| | - W. Sterry
- Department of Dermatology Charité – Universitätsmedizin Berlin Berlin Germany
| | - J.L. Bolognia
- Department of Dermatology Yale Medical School New Haven CT U.S.A
| |
Collapse
|
43
|
Otašević S, Barac A, Pekmezovic M, Tasic S, Ignjatović A, Momčilović S, Stojanović P, Arsic Arsenijevic V, Hay R. The prevalence of Candida onychomycosis in Southeastern Serbia from 2011 to 2015. Mycoses 2015; 59:167-72. [PMID: 26710983 DOI: 10.1111/myc.12448] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2015] [Revised: 10/22/2015] [Accepted: 11/18/2015] [Indexed: 12/01/2022]
Abstract
Despite the increasing of onychomycosis caused by Candida spp., in referent literature, there is still data insufficiency about this nail infection. The objectives of this retrospective study were to determine epidemiological characteristics of Candida onychomycosis, the antifungal susceptibility of isolated species in vitro, and to compare the results of antifungal susceptibility testing with conducted treatment in period from 2011 to the end of March 2015. Out of 761 patients who were underwent clinical and mycological examinations, 137 had Candida species isolated from nails. The dominant species was Candida albicans (C. albicans) (36.59%) followed by C. parapsilosis (23.78%), C. krusei (9.76%), and C. guilliermondii (6.71%). Antifungal susceptibility in vitro testing showed good susceptibility to antimycotics, except C. krusei, which was resistance to fluconazole (FCZ) and isolates of C. tropicalis and C. glabrata which were dose dependent to itraconazole (ITZ) and fluconazole. Evaluation of medical histories determined that combined therapy, which included pulsed systemic regimen of ITZ with topical application of clotrimazole, had better clinical outcomes regarding the proscribed only topical application of clotrimazole. Multidisciplinary approach of dermatologists and mycologists is required in solving the problem of onychomycosis, which is the dominant nail disease.
Collapse
Affiliation(s)
- Suzana Otašević
- Center of Microbiology and Parasitology, Public Health Institute Niš, Niš, Serbia.,Department of Microbiology and Immunology, Faculty of Medicine, University of Niš, Niš, Serbia
| | - Aleksandra Barac
- Department of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Marina Pekmezovic
- Department of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Sinisa Tasic
- Clinic for skin and veneral diseases, Clinical Center of Vojvodina, Novi Sad, Serbia
| | - Aleksandra Ignjatović
- Center of Microbiology and Parasitology, Public Health Institute Niš, Niš, Serbia.,Department of Medical Statistics, Faculty of Medicine, University of Niš, Niš, Serbia
| | - Stefan Momčilović
- Department of Microbiology and Immunology, Faculty of Medicine, University of Niš, Niš, Serbia
| | - Predrag Stojanović
- Center of Microbiology and Parasitology, Public Health Institute Niš, Niš, Serbia.,Department of Microbiology and Immunology, Faculty of Medicine, University of Niš, Niš, Serbia
| | - Valentina Arsic Arsenijevic
- Department of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.,National Medical Mycology Reference Laboratory, Department of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Roderick Hay
- Department of Dermatology, Skin Infection Clinic, Kings College Hospital NHS Trust, London, UK
| |
Collapse
|
44
|
Karimkhani C, Boyers L, Naghavi M, Coffeng L, Lott J, Wulf S, Hay R, Williams H, Weinstock M, Norton S, Armstrong A, Dunnick C, Norris D, Dellavalle R. The global burden of disease associated with alopecia areata. Br J Dermatol 2015; 172:1424-6. [DOI: 10.1111/bjd.13559] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- C. Karimkhani
- Columbia University College of Physicians and Surgeons; New York NY U.S.A
| | - L.N. Boyers
- Georgetown University School of Medicine; Washington DC U.S.A
| | - M. Naghavi
- Institute for Health Metrics and Evaluation; University of Washington; Seattle WA U.S.A
| | - L.E. Coffeng
- Institute for Health Metrics and Evaluation; University of Washington; Seattle WA U.S.A
| | - J.P. Lott
- Robert Wood Johnson Foundation Clinical Scholars Program; Yale University School of Medicine; New Haven CT U.S.A
- VA Connecticut Healthcare System; West Haven CT U.S.A
| | - S. Wulf
- Institute for Health Metrics and Evaluation; University of Washington; Seattle WA U.S.A
| | - R. Hay
- Department of Dermatology; Kings College Hospital NHS Trust; London U.K
| | - H.C. Williams
- Centre of Evidence Based Dermatology; University of Nottingham; U.K
| | - M.A. Weinstock
- Dermatoepidemiology Unit; VA Medical Center Providence; Providence RI U.S.A
- Department of Dermatology; Rhode Island Hospital; Providence RI U.S.A
- Departments of Dermatology and Epidemiology; Brown University; Providence RI U.S.A
| | - S.A. Norton
- Dermatology Division; Children's National Medical Center; Washington DC U.S.A
| | - A.W. Armstrong
- Department of Dermatology; University of Colorado Anschutz Medical Campus; Aurora CO U.S.A
- Dermatology Service; U.S. Department of Veterans Affairs; Eastern Colorado Health Care System; Denver CO U.S.A
| | - C.A. Dunnick
- Department of Dermatology; University of Colorado Anschutz Medical Campus; Aurora CO U.S.A
- Dermatology Service; U.S. Department of Veterans Affairs; Eastern Colorado Health Care System; Denver CO U.S.A
| | - D.A. Norris
- Department of Dermatology; University of Colorado Anschutz Medical Campus; Aurora CO U.S.A
- Dermatology Service; U.S. Department of Veterans Affairs; Eastern Colorado Health Care System; Denver CO U.S.A
| | - R.P. Dellavalle
- Department of Dermatology; University of Colorado Anschutz Medical Campus; Aurora CO U.S.A
- Dermatology Service; U.S. Department of Veterans Affairs; Eastern Colorado Health Care System; Denver CO U.S.A
- Department of Epidemiology; Colorado School of Public Health; University of Colorado Anschutz Medical Campus; Aurora CO U.S.A
| |
Collapse
|
45
|
Hube B, Hay R, Brasch J, Veraldi S, Schaller M. Dermatomycoses and inflammation: The adaptive balance between growth, damage, and survival. J Mycol Med 2015; 25:e44-58. [PMID: 25662199 DOI: 10.1016/j.mycmed.2014.11.002] [Citation(s) in RCA: 67] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2013] [Revised: 11/14/2014] [Accepted: 11/18/2014] [Indexed: 11/26/2022]
Abstract
Dermatomycosis is characterized by both superficial and subcutaneous infections of keratinous tissues and mucous membranes caused by a variety of fungal agents, the two most common classes being dermatophytes and yeasts. Overall, the stepwise process of host infection is similar among the main dermatomycotic species; however, the species-specific ability to elicit a host reaction upon infection is distinct. Yeasts such as Candida albicans elicit a relatively low level of host tissue damage and inflammation during pathogenic infection, while dermatophytes may induce a higher level of tissue damage and inflammatory reaction. Both pathogens can, however, manipulate the host's immune response, ensuring survival and prolonging chronic infection. One common element of most dermatomycotic infections is the disease burden caused by inflammation and associated signs and symptoms, such as erythema, burning and pruritus. There is a strong clinical rationale for the addition of a topical corticosteroid agent to an effective antimycotic therapy, especially in patients who present with inflammatory dermatomycoses (e.g., tinea inguinalis). In this review, we aim to compare the pathogenesis of common dermatomycotic species, including Candida yeasts (Candida albicans), dermatophytes (Trichophyton, Epidermophyton or Microsporum species), and other pathogenic yeasts (Malassezia), with a special focus on unique species-specific aspects of the respective infection processes, the interaction between essential aspects of pathogenic infection, the different roles of the host inflammatory response, and the clinical consequences of the infection-related tissue damage and inflammation. We hope that a broader understanding of the various mechanisms of dermatomycoses may contribute to more effective management of affected patients.
Collapse
Affiliation(s)
- B Hube
- Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute (HKI), Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany; Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany; Friedrich Schiller University, Jena, Germany
| | - R Hay
- Skin Infection Clinic, Kings College Hospital NHS Foundation Trust, London, UK
| | - J Brasch
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany
| | - S Veraldi
- Department of Medical and Surgical Physiopathology and Transplantations, University of Milan, I.R.C.C.S. Foundation, Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - M Schaller
- Department of Dermatology, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
| |
Collapse
|
46
|
Turton P, Hay R, Taylor JK, Little J, McPhee J, Welters I. Effect of prolonged critical care admissions on upper and lower limb muscle architecture. Crit Care 2015. [PMCID: PMC4471677 DOI: 10.1186/cc14553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
47
|
Affiliation(s)
- P. Lecerf
- Department of Dermatology and Venereology University Hospitals Saint‐Pierre Brugmann and Children's University Hospital Queen Fabiola Université Libre de Bruxelles 4 Place Van Gehichten 1020 Brussels Belgium
| | - R. Hay
- Skin Infection Clinic King's College Hospital NHS Trust Denmark Hill London SE8 3RS U.K
| |
Collapse
|
48
|
Fleming J, Fogo A, Haider S, Diaz-Cano S, Hay R, Bashir S. Varicella zoster virus brachioplexitis associated with granulomatous vasculopathy. Clin Exp Dermatol 2013; 38:378-81; quiz 382. [DOI: 10.1111/ced.12096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/17/2012] [Indexed: 11/29/2022]
Affiliation(s)
- J. Fleming
- Department of Dermatology; King's College Hospital; London; UK
| | - A. Fogo
- Department of Dermatology; King's College Hospital; London; UK
| | - S. Haider
- Department of Haematology; King's College Hospital; London; UK
| | - S. Diaz-Cano
- Department of Dermatology; King's College Hospital; London; UK
| | - R. Hay
- Department of Dermatology; King's College Hospital; London; UK
| | - S. Bashir
- Department of Dermatology; King's College Hospital; London; UK
| |
Collapse
|
49
|
Tietz HJ, Hay R, Querner S, Delcker A, Kurka P, Merk HF. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study. Mycoses 2013; 56:414-21. [DOI: 10.1111/myc.12037] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
|